AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9735677 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic mutations (677 CT and 1298 A‐C)
Number of subjects: 0
Study 8054436 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for Toxoplasma gondii
Number of subjects: 44
Study 8054436 — intervention group
Group type: COMPARATOR
Intervention: Untreated or treated for only 1 month
Number of subjects: 44
Study 2784320 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute propofol in 5% dextrose
Number of subjects: 100
Study 2784320 — intervention group
Group type: COMPARATOR
Intervention: Undiluted propofol
Number of subjects: 100
Study 4623288 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Diapulse machine emitting pulsed, high-frequency electrical energy
Number of subjects: 40
Study 4623288 — intervention group
Group type: COMPARATOR
Intervention: Non-active placebo machine
Number of subjects: 40
Study 31992301 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Department Supportive Care Clinical Decision Support (Support-ED) tool
Number of subjects: 0
Study 31992301 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care and Rapid Emergency Screening (P-CaRES) survey
Number of subjects: 0
Study 31992301 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical alerts triggered by specific patient scenarios
Number of subjects: 0
Study 31992301 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring and feedback on CDS functionality
Number of subjects: 0
Study 31319637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (12.5 mg, 2.5 mL)
Number of subjects: 66
Study 31319637 — intervention group
Group type: COMPARATOR
Intervention: Pethidine (1 mg/kg)
Number of subjects: 66
Study 28178132 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy leaving a unilateral remnant based on the upper pole (Group I)
Number of subjects: 168
Study 28178132 — intervention group
Group type: COMPARATOR
Intervention: Subtotal thyroidectomy with bilateral dorsal thyroid tissue remnant (Group II)
Number of subjects: 168
Study 25963290 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 30
Study 25963290 — intervention group
Group type: COMPARATOR
Intervention: Control group (no guided tissue regeneration techniques)
Number of subjects: 30
Study 24048551 — intervention group
Group type: EXPERIMENTAL
Intervention: BST‐CarGel treatment (n = 41)
Number of subjects: 80
Study 24048551 — intervention group
Group type: COMPARATOR
Intervention: Microfracture treatment alone (n = 39)
Number of subjects: 80
Study 21639636 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally Informed and Flexible Family‐Based Treatment for Adolescents (CIFFTA)
Number of subjects: 28
Study 21639636 — intervention group
Group type: COMPARATOR
Intervention: Traditional Family Therapy (TFT)
Number of subjects: 28
Study 19736179 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-treatment of exacerbations with an action plan including prednisolone (with or without antibiotics).
Number of subjects: 142
Study 19736179 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-treatment training).
Number of subjects: 142
Study 19736179 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-treatment group.
Number of subjects: 142
Study 16484554 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged garlic extract
Number of subjects: 0
Study 16484554 — intervention group
Group type: COMPARATOR
Intervention: Statin therapy
Number of subjects: 0
Study 15343110 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual teaching session conducted at discharge by a trained pharmacist
Number of subjects: 59
Study 15343110 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study 11022814 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularly scheduled follow-up interviews
Number of subjects: 188
Study 11022814 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Year-2 follow-up interviews
Number of subjects: 188
Study 11022814 — intervention group
Group type: COMPARATOR
Intervention: Missed scheduled follow-up interviews
Number of subjects: 188
Study 9282449 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional cleaning
Number of subjects: 80
Study 9282449 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (in addition to professional cleaning)
Number of subjects: 80
Study 9282449 — intervention group
Group type: COMPARATOR
Intervention: No treatment (third group)
Number of subjects: 80
Study 9282449 — intervention group
Group type: COMPARATOR
Intervention: No treatment (fourth group)
Number of subjects: 80
Study 9282449 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional cleaning (fifth group)
Number of subjects: 80
Study 8380610 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir (5 mg/kg every 12 hours for 14 days)
Number of subjects: 62
Study 8380610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 29034719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP)
Number of subjects: 20
Study 29034719 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 28851099 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-ml autologous platelet-rich plasma (PRP) injection
Number of subjects: 156
Study 28851099 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy without injection (Control)
Number of subjects: 156
Study 27372556 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-balance technique (SB group)
Number of subjects: 60
Study 27372556 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopy-view technique (AV group)
Number of subjects: 60
Study 25305376 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthValues Healthy Eating Programme (internet-based intervention)
Number of subjects: 100
Study 25305376 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 100
Study 22441004 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on pioglitazone (DP group)
Number of subjects: 98
Study 22441004 — intervention group
Group type: COMPARATOR
Intervention: Add-on sulfonylurea (DS group)
Number of subjects: 98
Study 20202819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine with clonidine 75 microg
Number of subjects: 60
Study 20202819 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine with sufentanil 5 microg
Number of subjects: 60
Study 18486923 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies targeting adhesion molecules
Number of subjects: 0
Study 17699341 — intervention group
Group type: EXPERIMENTAL
Intervention: Satavaptan 25 mg
Number of subjects: 34
Study 17699341 — intervention group
Group type: EXPERIMENTAL
Intervention: Satavaptan 50 mg
Number of subjects: 34
Study 17699341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 17699341 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term treatment with Satavaptan
Number of subjects: 34
Study 12689734 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs (specific drugs and dosages not mentioned)
Number of subjects: 0
Study 12689734 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogate endpoints (time to virological failure and time to regimen termination)
Number of subjects: 0
Study 10953651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (n-CPAP)
Number of subjects: 0
Study 8923574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 300 mg/day
Number of subjects: 47
Study 8923574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg/day
Number of subjects: 47
Study 8923574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 600 mg/day
Number of subjects: 47
Study 8923574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (all doses)
Number of subjects: 47
Study 1395879 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision of pilonidal sinus with insertion of a collagen sponge containing Gentamicin and primary suture (group 1)
Number of subjects: 40
Study 1395879 — intervention group
Group type: COMPARATOR
Intervention: Excision of pilonidal sinus without applying the Gentamicin-collagen sponge (group 2)
Number of subjects: 40
Study 2986508 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir (400 mg five times daily for 10 days)
Number of subjects: 21
Study 2986508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30730794 — intervention group
Group type: EXPERIMENTAL
Intervention: Revitalization using blood clot scaffold only
Number of subjects: 22
Study 30730794 — intervention group
Group type: COMPARATOR
Intervention: Revitalization using blood clot and PRF
Number of subjects: 22
Study 30081075 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait retraining
Number of subjects: 23
Study 30081075 — intervention group
Group type: COMPARATOR
Intervention: Walking exercise
Number of subjects: 23
Study 26723241 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib + PCI
Number of subjects: 85
Study 26723241 — intervention group
Group type: COMPARATOR
Intervention: Placebo + PCI
Number of subjects: 85
Study 24655007 — intervention group
Group type: EXPERIMENTAL
Intervention: vodka/tonic (20% v/v)
Number of subjects: 15
Study 24655007 — intervention group
Group type: EXPERIMENTAL
Intervention: white wine (12.5% v/v)
Number of subjects: 15
Study 24655007 — intervention group
Group type: EXPERIMENTAL
Intervention: beer (5.1% v/v)
Number of subjects: 15
Study 22490620 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-implemented language intervention (24 biweekly 1-hr sessions for 3 months)
Number of subjects: 34
Study 22490620 — intervention group
Group type: COMPARATOR
Intervention: Control group (nontreatment experimental condition)
Number of subjects: 34
Study 22490620 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-implemented language intervention
Number of subjects: 34
Study 19889887 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to the online system and a training programme for GPs (Group 1)
Number of subjects: 112
Study 19889887 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to the online system and education for the whole practice team (Group 2)
Number of subjects: 112
Study 19889887 — intervention group
Group type: COMPARATOR
Intervention: Access to the online system only (Control Group)
Number of subjects: 112
Study 16928464 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise intervention
Number of subjects: 146
Study 16276174 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie PN (20 nonprotein kilocalories per kg per day)
Number of subjects: 40
Study 16276174 — intervention group
Group type: COMPARATOR
Intervention: Standard PN (30 nonprotein kilocalories per kg per day)
Number of subjects: 40
Study 12060512 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ALA-PDT
Number of subjects: 0
Study 10450013 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA)
Number of subjects: 36
Study 7587985 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0
Study 7587985 — intervention group
Group type: COMPARATOR
Intervention: Traditional slow‐acting antirheumatics (gold, sulphasalazine, penicillamine)
Number of subjects: 0
Study 2360741 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride (10 mg/kg, n = 8)
Number of subjects: 15
Study 2360741 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium gluconate (30 mg/kg, n = 7)
Number of subjects: 15
Study 74607 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 90
Study 74607 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 31269677 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Intervention (HI) at 70% of 1RM
Number of subjects: 18
Study 31269677 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity with Blood Flow Restriction (LI-BFR) at 30% of 1RM
Number of subjects: 18
Study 31269677 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity without Blood Flow Restriction (LI) at 30% of 1RM
Number of subjects: 18
Study 27450789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's local anesthesia during induction
Number of subjects: 268
Study 27450789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's local anesthesia during maintenance
Number of subjects: 268
Study 27450789 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification surgery
Number of subjects: 268
Study 25975474 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C
Number of subjects: 686
Study 25975474 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 36°C
Number of subjects: 686
Study 25975474 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE levels assessed at 24, 48, and 72 h after return of spontaneous circulation
Number of subjects: 686
Study 23842536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (1 mg/kg)
Number of subjects: 72
Study 23842536 — intervention group
Group type: COMPARATOR
Intervention: Intranasal fentanyl (1.5 microgram/kg)
Number of subjects: 72
Study 23842536 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen (10 mg/kg)
Number of subjects: 72
Study 21939716 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi polysaccharide vaccine
Number of subjects: 60000
Study 21939716 — intervention group
Group type: COMPARATOR
Intervention: Inactivated hepatitis A vaccine
Number of subjects: 60000
Study 19361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and Western medicine therapy without antibiotics
Number of subjects: 54
Study 19361362 — intervention group
Group type: COMPARATOR
Intervention: Imipenem‐cilastatin (0.5 g every eight hours for ten days)
Number of subjects: 54
Study 16922757 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA-U
Number of subjects: 300
Study 16922757 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-LM
Number of subjects: 300
Study 16922757 — intervention group
Group type: COMPARATOR
Intervention: Cobra-PLA
Number of subjects: 300
Study 12712780 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg
Number of subjects: 28
Study 12712780 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 2 mg/kg
Number of subjects: 28
Study 11059520 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid therapy
Number of subjects: 0
Study 11059520 — intervention group
Group type: COMPARATOR
Intervention: Systemic glucocorticoid therapy
Number of subjects: 0
Study 8874677 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong training
Number of subjects: 0
Study 1412754 — intervention group
Group type: EXPERIMENTAL
Intervention: Double therapy with cyclosporine and prednisolone
Number of subjects: 463
Study 1412754 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy with cyclosporine, azathioprine, and prednisolone
Number of subjects: 463
Study 1412754 — intervention group
Group type: EXPERIMENTAL
Intervention: Double therapy with cyclosporine and prednisolone (subgroup with azathioprine)
Number of subjects: 463
Study 3927371 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP)
Number of subjects: 0
Study 30474791 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen (800 mg)
Number of subjects: 90
Study 30474791 — intervention group
Group type: EXPERIMENTAL
Intervention: IV paracetamol (1000 mg)
Number of subjects: 90
Study 30474791 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 ml saline solution)
Number of subjects: 90
Study 30485422 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence intervention for patients not taking DMT due to avoidance reasons
Number of subjects: 78
Study 28412755 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (group S, n = 25)
Number of subjects: 50
Study 28412755 — intervention group
Group type: COMPARATOR
Intervention: Intravenous propofol anesthesia (group P, n = 25)
Number of subjects: 50
Study 26037276 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video games (AVG) for 16 weeks
Number of subjects: 21
Study 26037276 — intervention group
Group type: COMPARATOR
Intervention: Normal activities (NAG) for 16 weeks
Number of subjects: 21
Study 24246616 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole (20mg/day)
Number of subjects: 36
Study 24246616 — intervention group
Group type: COMPARATOR
Intervention: omeprazole (20mg/day)
Number of subjects: 36
Study 24246616 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 21677059 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% l-arabinose in sucrose beverages
Number of subjects: 15
Study 21677059 — intervention group
Group type: COMPARATOR
Intervention: Control (0% l-arabinose in sucrose beverages)
Number of subjects: 15
Study 19111776 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical motion in the same direction as the oblique motion
Number of subjects: 0
Study 19111776 — intervention group
Group type: COMPARATOR
Intervention: Vertical motion in the opposite direction to the oblique motion
Number of subjects: 0
Study 19111776 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased speed of vertical motion
Number of subjects: 0
Study 16952809 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural space expansion with 10 mL dextrose 5% in water (D5W) flush before catheter placement
Number of subjects: 60
Study 16952809 — intervention group
Group type: COMPARATOR
Intervention: No perineural space expansion
Number of subjects: 60
Study 16952809 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural space expansion
Number of subjects: 60
Study 15291224 — intervention group
Group type: EXPERIMENTAL
Intervention: Singer's Five‐step Strategy introduced prior to starting acquisition trials (100% group)
Number of subjects: 50
Study 15291224 — intervention group
Group type: EXPERIMENTAL
Intervention: Singer's Five‐step Strategy introduced after acquisition Trial Block 1 (83% group)
Number of subjects: 50
Study 15291224 — intervention group
Group type: EXPERIMENTAL
Intervention: Singer's Five‐step Strategy introduced after acquisition Trial Block 3 (50% group)
Number of subjects: 50
Study 15291224 — intervention group
Group type: EXPERIMENTAL
Intervention: Singer's Five‐step Strategy introduced after acquisition Trial Block 5 (17% group)
Number of subjects: 50
Study 15291224 — intervention group
Group type: COMPARATOR
Intervention: Control group (0% group)
Number of subjects: 50
Study 11293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Yes-no task
Number of subjects: 0
Study 11293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-choice task
Number of subjects: 0
Study 9444798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoblastoid a‐IFN (3MU i.m. every two days for 2 months, then 6MU i.m. every second two days for additional 10 months)
Number of subjects: 100
Study 9444798 — intervention group
Group type: COMPARATOR
Intervention: Non-specific support therapy (control)
Number of subjects: 100
Study 9444798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoblastoid a‐IFN
Number of subjects: 100
Study 7942533 — intervention group
Group type: EXPERIMENTAL
Intervention: 81 mg aspirin
Number of subjects: 18
Study 7942533 — intervention group
Group type: EXPERIMENTAL
Intervention: 162 mg aspirin
Number of subjects: 18
Study 7942533 — intervention group
Group type: EXPERIMENTAL
Intervention: 324 mg aspirin
Number of subjects: 18
Study 7942533 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of aspirin (81, 162, 324 mg)
Number of subjects: 18
Study 3203047 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ouabain (1 mg)
Number of subjects: 16
Study 3203047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29893977 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder Movement Intervention (ShoMo)
Number of subjects: 52
Study 29893977 — intervention group
Group type: COMPARATOR
Intervention: Wellness Intervention
Number of subjects: 52
Study 27585484 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual search training
Number of subjects: 340
Study 27585484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dot-probe training
Number of subjects: 340
Study 27585484 — intervention group
Group type: COMPARATOR
Intervention: Placebo control conditions
Number of subjects: 340
Study 25146059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with essential oils
Number of subjects: 57
Study 25146059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure only
Number of subjects: 57
Study 25146059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with or without essential oils
Number of subjects: 57
Study 25146059 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 57
Study 23742676 — intervention group
Group type: COMPARATOR
Intervention: Subclinical hyperthyroidism (group II)
Number of subjects: 93
Study 23742676 — intervention group
Group type: COMPARATOR
Intervention: Overt hyperthyroidism (group III)
Number of subjects: 93
Study 21283156 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatifloxacin (Zymar) and masked dexamethasone 0.1% (Maxidex)
Number of subjects: 30
Study 21283156 — intervention group
Group type: COMPARATOR
Intervention: Gatifloxacin (Zymar) and a masked placebo
Number of subjects: 30
Study 20058619 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 140
Study 20058619 — intervention group
Group type: COMPARATOR
Intervention: Control (non-metformin)
Number of subjects: 140
Study 16498000 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage procedure
Number of subjects: 168
Study 16498000 — intervention group
Group type: COMPARATOR
Intervention: Two-stage procedure
Number of subjects: 168
Study 15799920 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally endoscopic approach
Number of subjects: 17
Study 15799920 — intervention group
Group type: COMPARATOR
Intervention: Minithoracotomy group
Number of subjects: 17
Study 15799920 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally endoscopic group
Number of subjects: 17
Study 10917406 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH 4-10 (1 mg single dose)
Number of subjects: 60
Study 10917406 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH 4-10 (1 mg/day for 6 weeks)
Number of subjects: 60
Study 10917406 — intervention group
Group type: COMPARATOR
Intervention: Desacetyl-alpha-MSH (equimolar doses)
Number of subjects: 60
Study 9293327 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean prep kits
Number of subjects: 60